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1. Introduction 
A single point mutation in the to&I gene of Esche- 
richiu coli results in an apparently diverse phenotype. 
Strains with a tonB gene lesion are simultaneously 
insensitive to phage T, and @so [11, and insensitive to 
colicins from group B [2]. They also lack specific iron- 
transport systems for ferric enterochelin [3], ferri- 
chrome [4], ferric citrate [3], rhodoturulic acid [5] 
and an unidentified hydroxymate siderophore derived 
from a ColV plasmid [6,7], and a transport system 
for the cobalt complex, vitamin Brz [8] (table 1). 
pathway. In [20] a tonB strain had de-repressed levels 
of these enzymes resulting from iron starvation of the 
tonB strain by its inability to transport iron-chelated 
molecules. to&3 (formerly exbA) strains hyperexcrete 
enterochelin [23], also a product of the aromatic bio- 
synthetic pathway. In tonB strains, iron starvation 
also effects de-repressed levels of certain major pro- 
teins in the outer membrane [9,24] and minor pro- 
teins responsible for the binding of some group B 
coliclns [25] including colicin I [26]. 
1.1. Genetics 
Receptors in the outer membrane of E. coli are 
involved in the transport of these ferric complexes 
[4,9-121 and vitamin Brz [ 131, and serve as specific 
binding sites for certain colicins and phage [10,14-l 71 
(table 1). The specific binding of colicins or phage to 
their receptors is inhibited by the specific substrate 
(iron-siderophore orvitamin Brz) resulting in inhibi- 
tion of the killing action of that colicin [ 181. The 
irreversible binding of phage T, and tps,, required the 
membrane potential and TonB function [ 191 (TonB 
protein = tonB gene product). Thus, TonB function 
was associated with the outer membrane. However, 
not all functions associated with the receptors are 
TonB-dependent; these are summarised in table 1 and 
discussed below. 
,The tonB allele has been mapped at min 27 on the 
chromosomal map of E. coli [27], close to the trypto- 
phan operon. Between 10% [9] and 25% [28] of 
mutants resistant to the ferrichrome analogue and 
antibiotic, albomycin, are tonB strains. tonB strains 
have also been isolated by selection for resistance to 
colicins B [29] and I [52], and were resistant to 
phage Tr [30]. Many tonB strains are deletions 
[23,30,31], the length and frequency of the deletion 
depending on the tonB strain and nearby chromoso- 
mal material. 
A defunct tonB leads to other pleiotropic effects 
derived from an inability to actively accumulate iron, 
and thus from iron starvation. Several enzymes in the 
biosynthetic pathway for aromatic amino acids and 
vitamins were de-repressed under conditions of iron 
tarvation in wild-type strains [20,21]. This effect is 
nediated by iron-dependent modification enzymes of 
tRNA [22] involved in attenuation control of genes 
(:oding for key enzymes of the aromatic biosynthetic 
Fine mapping of the to&3 region using restriction 
enzyme analysis was presented in [27]. They mobi- 
lised the tonB region onto a ColEl plasmid which 
complemented a tonB strain. In [32] a to& plasmid 
was employed in minicells and a 1730 basepair Hind11 
fragment [27] defined which produced a 36 000 Mr 
protein responsible for the TonB function [32]. In 
[33] a tonB’ plasmid was mobilised onto X-transduc- 
ing phage and a tonB gene product (TonB) of 
40 000 Mr found; this protein was largely associated 
with the cytoplasmic membrane fraction [33]. The 
tonB operon is a single gene which is transcribed in a 
clockwise direction [32]. The complementation f a 
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Table 1 
Summary of the gross characteristics of TonBdependent systems 
System 
fep 
Substrate 
Ferric enterochelin 
Map posi- 
tion on 
chromosome 
13 min 
Receptor 
FepA 
Permease 
FepB 
Factors which utilize system 
TonBdependent TonB-independent 
Ferric enterochelin 
Colicin B None known 
Colicin D 
Fu Ferrichrome 3min FhuA 
(formerly TonA) 
FhuB Ferrichrome 
Albomycin 
Colicin M 
Phage T, 
Phage @so 
Phage T, 
btu Vitamin B,, 
(cyanocobalamin) 
89 min BtuB BtuA(?) 
BtuC(?) 
Vitamin B,, Colicin E, 
Colicin E, 
Colicin E, 
Phage BF23 
fee 
? 
Ferric citrate 6 min 
Rhodoturulic acid ? 
FecA 
? 
FecB 
FhuB 
Ferric citrate 
Rhodoturulic acid 
None known 
None known 
tonB strain by a tonB’ plasmid indicates that the 
ton@ gene is transdominant [32]. 
1.2. Physiology 
Dihydroxybenzoate (DHB), the metabolic precur- 
sor of enterochelin, stimulated growth of a tonB aroB 
strain at <5 I.IM but at higher concentrations progres- 
sively inhibited the growth rate during log phase [3]. 
DHB had similar effects on the incorporation of iron 
into a tonB strain [9]. According to [3], at low 
[DHB], small concentrations of enterochelin are 
excreted into the periplasmic space chelating available 
iron, which is then taken up via the fep system (review 
[34]) into the cytoplasm. As in the wild-type, ferric 
enterochelin is subsequently broken down by the fer- 
ric enterochelin esterase cfes gene product) into ferric- 
dihydroxy benzoyl serine, and the Fe3+ incorporated 
into proteins by ferrochelatase [35]. In the tonB aroB 
strain, higher [DHB] resulted in the biosynthesis of 
higher concentrations of enterochelin which was 
excreted into the extracellular medium chelating the 
available iron, and rendering it unavailable for uptake 
due to the putative block in the outer membrane. 
That the irreversible binding of phage T, was dependent 
on TonB function and on membrane potential [ 191, 
led to the proposal that the function of TonB was to 
energize transport across the outer membrane [36]. 
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Not all transport systems which have a receptor in 
the outer membrane are TonB-dependent , e.g., uptake 
of maltose [8 J and nucleosides via the receptors coded 
by the ZumB [37-391 and tsx genes [40,41], respec- 
tively. h-Phage requires the maltose receptor to infect 
the cell while phage T6 and colicin K use the tsx gene 
product in the outer membrane. 
The function of TonB in energy transduction was 
supported by [42-&l]. Activity of the vitamin Blz 
transport system declined rapidly when a tonB (Am) 
supD (Ts) strain was incubated at the non-permissive 
temperature [42]; this decline was associated with the 
energy-dependent phase of uptake rather than the ini- 
tial binding to the receptor [42]. Loss of protein syn- 
thesis also resulted in a rapid decline in the energy- 
dependent phase of vitamin Biz uptake [43]. The 
rapid decline in TonB function as compared to the 
function of the vitamin Bi2 receptor implied that the 
tonB gene product may be an energy source for the 
relevant systems. 
In [43,44] an end strain grown with dlhydroxy- 
benzoate or with ferrichrome, had a reduced initial 
velocity of vitamin Bi2 uptake. In [ 181 ferric entero- 
chelin or ferrichrome, but not the chromium deriva- 
tive of ferrichrome, conferred resistance simulta- 
neously to group B colicins, including colicins B, V 
and Ia. The basic mechanism clearly involves the avail. 
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ability of iron rather than inhibition at the receptor 
by the siderophore itself [ 181. 
2. Discussion of existing hypotheses 
Since the data iu [3] were interpreted as indirectly 
supporting the hypothesis that a defective toti gene 
product gave rise to a functional lesion in the outer 
membrane, most subsequent data were interpreted to 
fit a similar model. One variation of this model 
[8,42,45-j envisaged the TonB function as coupling 
the activity of the receptor to the permease in the 
cytoplasmic membrane by promoting the release of 
substrates from the respective receptors into the peri- 
plasmic space thereby making it available to the per- 
mease on the cytoplasmic membrane [46]. The vita- 
min Br2-transport system has been researched most 
extensively. While BtuA phenotypes lacked the abil- 
ity to actively accumulate vitamin Brz, BtuB pheno- 
types also lacked a receptor in the outer membrane 
capable of binding the substrate [47]. If these 2 pheno- 
types have separate genes, they are not separable by 
complementation a alysis 1481. Characteristics of 
btuB and b&4 mutants from [ 16,47,48] are listed in 
table 2. 
btuA and tonB strains hare characteristics which 
suggest that both possess afunctional receptor in the 
outer membrane: 
(i) Strains of both types are sensitive to BF23 and 
colicins of the E type; 
(ii) Membrane preparations of both types ‘neutralise’ 
the effects of these antagonists; 
(iii) Both lack the energy-dependent phase of vita- 
min Br2 transport, although they bind the sub- 
strate, as does the parent. 
The BtuB phenotype may arise from a defect of the 
receptor in the outer membrane while BtuA may arise 
from a defect in the permease. This contradicts [45] 
where 2 binding states are proposed for the receptor: 
(i) BtuA, responsible for the binding of vitamin Brz; 
(ii) BtuB, responsible for the attachment of colicins E 
and phage BF23. My interpretation agrees with that 
found in the ferrichrome transport system where the 
j?zuA gene codes for the ferrichrome receptor in the 
outer membrane while the jhuB gene codes for the 
permease in the cytoplasmic membrane [28,50].~7zuA 
mutants are resistant to phage T,, Ts and es,,, to col- 
icin M and albomycin, and are unable to take up ferri- 
chrome.j&uB mutants are sensitive to this phage 
and colicin M (with exceptions), insensitive to albo- 
mycin, and are unable to accumulate f rrichrome. 
This interpretation also agrees with that proposed for 
thefep system [51]. 
Indirect evidence for TonB funtion in energy cou- 
pling to conformational changes of receptors in the 
outer membrane includes observations on colicin M 
action [52-541 and the binding requirements of
phage T,, T5 and @se and inhibition by ferrichrome 
[ 19,28,36]. 
An alternative hypothesis ees TonB function in 
terms of energy required for generation of sites of 
apposition between the outer and cytoplasmic mem- 
branes [55]. These sites are distinguished from those 
in [56]. However, there is little evidence for such a 
mechanism [ 5 51. 
That TonB function is unrelated to processes in 
the outer membrane and energization of transport is 
suggested by: 
(i) Receptors of the vitamin Brz- (b&B) and ferri- 
chrome-transport systems CfhuA) serve as recep- 
Table 2 
The characteristics of strains defective in vitamin B,, utilization 
Relevant 
genotype 
Presence or absence of vitamin B,, 
(i) Binding (ii) Uptake 
Growth-limiting 
[vitamin B, Z ] (M) 
Sensitivity to col- 
icins E, and E, 
Sensitivity to 
phage BF23 
Parent 
btuB(II) 
btuB(II1) 
btuA 
btuC 
tonB-45 1 
tonB452 
Present 
Absent 
Absent 
Present 
Present 
Present 
Present 
Present 
- 
_ 
Absent 
Present 
Absent 
Absent 
5 x lo-” 
5 x lo-I0 
5 x lo-’ 
5 x lo-’ 
5 x lo-‘O 
5 x lo-* 
5 x 1o-‘o 
Sensitive 
Resistant 
Resistant 
Sensitive 
Sensitive 
Sensitive 
Sensitive 
Sensitive 
Resistant 
Resistant 
Sensitive 
Sensitive 
Sensitive 
Sensitive 
147 
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(iii) 
tors for their substrates, for the infection and 
killing by phage BF23 and colicins E,, Ez and E3 
with btuB, and for phage TS withj?ruA (table 1). 
Strains with tonB lesions continue to be sensitive 
to these antagonists although defective in their 
capacity to transport he corresponding ligands. 
Cell suspensions treated to make their outer mem- 
brane more permeable to ferric enterochelin [5 1 ] 
and ferrichrome [50] remain dependent on the 
TonB function for these transport processes. Cell 
suspensions were made permeable to substances 
with an &value about that of actinomycin by 
treatment with pronase. Strains lacking a func- 
tional receptor for ferrichrome CfhuA) were able 
to take up ferrichrome only after pronase treat- 
ment. Strains which were tonB orfir.& (lacking 
the permease for ferrichrome uptake) were both 
unable to transport ferrichrome before or after 
pronase treatment. 
TonB function may not be related to energy 
transformation processes at all, at least in rela- 
tion to the uptake of ferrichrome and ferric 
enterochelin (see below). 
2.1. TonB finction in the energization of iron uptake? 
Genetic and physiological techniques have been 
used to determine at what stage during the transport 
process the TonB function is required for energiza- 
tion, if at alI: 
In the ferric enterochelin transport system a 
receptor in the outer membrane (FepA, [S 11) serves 
for the uptake of ferric enterochelin and for binding 
of colicins B and D [lo]. A permease (FepB) exists 
for transport across the cytoplasmic membrane [51]; 
and, based on enzyme yields from shocked cells, the 
ferric enterochelin esterase cfes) is thought o be local- 
ized solely in the cytoplasm (Braun, personal commu- 
nication) and not in the cytoplasmic membrane as 
claimed in [55]. fes mutants camrot use ferric entero- 
chelin as an iron source [35] although they can accu- 
mulate this substrate. In a fes strain, [“Fe] ferric 
enterochelin, ferric [ 14C]enterochelin a d [ r4C] entero- 
chelin are accumulated to similar steady-state l vels 
(fig.1). Since enterochelin contains no iron, its accu- 
mulation excludes the possibility that iron reduction 
is a prerequisite for transport [581. 
Ferric enterochelin uptake is sensitive to energy 
148 
A 
/ 
600 
. 
/ 
I I . k= 0 
300 
10 20 ( 
Time imind 
B 
A I 
. F . 
a-+--- 
Tim:? mi do 
Fig.1. Uptake of iron and enterochelin by suspensions of (A) 
parent AN92 cells and (B) fes AN272 cells, after growth in 
1 mM citrate and as in [ 3,571. The uptake medium contained 
100 PM nitrilotriacetic acid to inhibit the low affinity iron 
uptake system and either 2 PM [ W]enterochelin (A) or 2 PM 
[ Wlenterochelin + l_rM Fe’+ (e) or 1 PM “Fe3+ (0) or 
2 PM enterochelin + 1 bM “Fe’+ (0). 
uncouplers [59]. A fes strain was used to characterize 
the energization of ferric enterochelin uptake [60]: 
both ferric enterochelin and proline accumulation 
required energy from the membrane potential under 
aerobic and anaerobic onditions. A striking exception 
[60] was the inability of dinitrophenol (DNP) to pro- 
mote the efflux of accumulated [“Fe] ferric entero- 
chelin from a fes strain at the steady-state, in contrast 
to its effect on [ r4C] proline. DNP added during this 
steady-state stage inhibited the efflux of [“Fe] ferric 
enterochelin when a lo-fold excess of non-radioactive 
ferric enterochelin was added in a ‘chase’ experiment 
[60]. At pH 7 ferric enterochelin has 3 units of nega- 
tive charge while proline has <l unit. In line with the 
chemiosmotic theory, the component of the mem- 
brane potential utilized by the ferric enterochelin 
transport system may be different from that utilized 
by the proline system. 
Ferrichrome uptake may be energized by the acet- 
ylation of the accumulated substrate before its rapid 
excretion [63] and not by the membrane potential 
(in contrast o the ferric enterochelin system). Cell 
smashes of tonB strains can acetylate ferrichrome, 
suggesting that the TonB function is not linked to 
this process. Thus, whether or not there is a common 
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process in the energization of ferric enterochelin and 
ferrichrome transport systems, which may be attri- 
buted to the TonB function, remains open. 
2.2. An alternative rationale of DHB stimulation of 
tonB strains 
Dihydroxybenzoate (DHB) at <5 PM stimulated 
the growth of a tonB aroB strain in a substantially 
iron free medium (1 ,uM) [3]. Higher concentrations 
of DHB, progressively inhibited growth. The DHB 
effect was in fact an enterochelin effect, since a tonB 
entF strain did not respond to DHB [3]. An alterna- 
tive hypothesis could be postulated when the growth 
rate was observed to be determined by the ratio of 
ferric enterochelin to enterochelin i  the growth 
medium. In [3], the ferric enterochelln/enterochelin 
ratio increased to -1 with 6 pM DHB (the medium 
contained -1 PM Fe3+ , and 6 I.~M DHB, if fully used, 
is converted into 2 PM enterochelin). With increasing 
DHB levels the ratio approaches zero. Why the ferric 
enterochelin/enterochelin ratio is critical for the 
growth of tonB strains is explained by the following 
unpublished ata: 
(i) Enterochelin (10 PM) inhibits the uptake of 
[“Fe] ferric enterochelin (1 MM) into parental 
strains by -10%. 
(ii) Enterochelin (10 PM) inhibits the incorporation 
of “Fe3+ from ferric enterochelin (1 PM) into a 
tonB strain. 
(iii) Enterochelin (10 PM) inhibits the binding of 
[“Fe] ferric enterochelin to FepA receptor sites 
in parental and tonB strains. 
(iv) The growth rate of a to&l aroE strain could be 
manipulated by varying the ferric enterochelin/ 
enterochelin ratio in the growth medium. The 
growth rate is dependent on this ratio and not on 
total [ Fe3+] of the medium (fig.2). 
Why ferric enterochelin/enterochelin ratio is more 
critical ln a tonB strain than in its parent may be 
explained by the relative rates of uptake of [“Fe] fer- 
rlc enterochelin. The rate of [“Fe] ferric enterochelin 
uptake into a tonB strain is almost zero [3]. However, 
tonB (but not fepB) strain growth on ferric entero- 
chelin and incorporation of 55Fe3+ from [“Felferric 
enterochelin i  a tonB strain, suggests hat the FepB 
permease ispresent in lowered amounts or may oper- 
ate with reduced efficiency. Reduction in this low 
rate by inhibition with enterochelin i  a to&l strain 
would lead to iron deprivation and consequent inhibi- 
tion of growth. The defect of the ferric enterochelin 
1.0 -
- 
(7.5) tla 
&J(2) 
0 1.0 2.0 3.0+ w 
Ferric enterochelin/Entemchelin Ratio 
Fig.2. The effect of various ferric enterochelin/enterochelin 
ratios on the growth velocity of tonI3 strain BR158 during expe 
nential phase. Enterochelin was estimated to be 10 PM [ 821. 
Added iron (JJM) is shown in parentheses at each point on the 
curve. 
uptake system in a tonB strain is proposed to be in 
the lowered activity of the permease rather than a 
putative block in translocation across the outer mem- 
brane. In the vitamin Brz system to&l strains are 
‘leaky’ to vitamin Brz. In comparison with a btuB 
strain which lacks a functional receptor in the outer 
membrane, tonB strains can grow on 1 O-l 03-fold 
lower concentrations of vitamin Brz, albeit at levels 
higher than required for growth of the parent itself. 
Since TonB-dependent transport systems may not 
contain a common energy-dependent step which 
could be attributed to the TonB function, and tonB 
strains ‘leak’ TonBdependent substrates like ferric 
enterochehn and vitamin Brz, an hypothesis is now 
presented which explains both the genotypic and 
phenotypic haracteristics of tonB strains. 
3. Hypothesis 
(1) The tonB gene product acts in the molecular 
processing of the relevant permeases, either: 
149 
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(4 
Or 
@I 
As a positive regulator of the permease genes 
for the transport systems of ferric enterochelin, 
ferrichrome, ferric citrate, rhodoturulic acid, 
vitamin Brz and any other TonBdependent 
substrate; 
The tonB gene product acts as a specific pro- 
tease which modifies the proteins FepA, BtuB, 
FecA and FhuB to act as permeases in the 
cytoplasmic membrane rather than receptors 
in the outer membrane (except FhuB). 
(2) Permeases of TonB-dependent systems are func- 
tionally unstable. The activity of these transport sys- 
tems requires continuous protein synthesis. 
(3) The action of group B colicins requires func- 
tional cytoplasmic membrane proteins, some or all of 
which may be TonBdependent permeases, which 
require the tonB gene product for their expression. 
(4) The irreversible binding of phage T, and &,, 
[ 191 requires acytoplasmic membrane protein which 
may be the tonB gene product or some protein pro- 
duced as a result of positive regulation by the TonB 
protein. 
3.1. The tonB gene product as a positive regula- 
tor (1 (a)) 
Integrated metabolic systems for sugars [65], 
amino acids [66,67] and phage replication [68,69] in 
bacteria contain control mechanisms capable of posi- 
tively regulating ene expression. 
The main criteria for establishing the existence of 
positive regulators of structural genes have been dis- 
cussed in [70]. Those for which evidence is available 
TonB are discussed below. 
(i) The occurrence of pleiotropic-negative mutants at 
high frequency similar to that found in a structural 
gene, may be taken as presumptive evidence for a 
positive regulator 
Of strains elected for resistance to albomycin, an 
antibiotic of similar structure to ferrichrome, between 
‘10% [9] and 25% [28] of resistant strains mapped 
close to the tryptophan region indicating that they 
are probably tonB. These figures represent ahigh fre- 
quency of to&3 strains. The pleiotropic nature of 
tonB strains has been discussed. 
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(ii) The isolation of a deletion mutation (or a few 
nonsense mutations) in the proposed regulatory 
gene whose phenotypic expression results in the 
failure to induce or derepress structural genes in 
one or more operons (pleiotropic-negative 
mutants, R-) 
A large number of tonB strains are deletions [23,30]. 
The length of the deletion varies and depends on the 
nature of the chromosome surrounding this region 
[31]. These mutants cannot accumulate various iron- 
chelators and vitamin B r2 for which distinct ransport 
systems exist (see above) and hence fail to induce the 
structural genes. 
(iii) Demonstration that the regulatory gene is not 
part of the operon(s) that it is proposed to control 
The map position of the to&3 allele (min 27) on the 
chromosome of E. coli is quite different from those 
operons that it is proposed to control; i.e., operons 
responsible for the transport of ferric enterochelin 
(mm 13) ferrichrome (min 3) ferric citrate (mm 6) 
and vitamin Brz (min 89). 
(iv) Test for dominance: R’ (wild-type, inducible 
allele) and Rc alleles should be dominant to R- 
The tonB+ gene on a plasmid is dominant over a tonB 
lesion on the chromosome [Jl]. 
Although these conditions are largely fulfilled by the 
characteristics of the tonB gene, an important criter- 
rion remains unsubstantiated: constitutive strains able 
to accumulate f rrichrome (for example) but remain- 
ing tonB, should be isolated. Such strains would have 
a mutation in the fhuB operator egion which allows 
expression of that gene without positive regulation by 
the TonB protein. A number of the conditions out- 
lined in [70] are fulfdled suggesting that the TonB 
protein acts as a positive regulator (activator) of per- 
mease genes involved in iron and vitamin Blz transport. 
Little is known of the number and tine structure 
of fhu, fep, fee and btu genes in terms of promoter 
and operator egions, and base sequences. With fhu 
genes, merodiploid analysis [28] showed that j7ruA 
and fhuB genes are necessary for the uptake of ferri- 
chrome. In [50] a functional J?zwl gene product was 
shown necessary for the receptor function in the 
outer membrane while fhuB is required for transport 
across the cytoplasmic membrane, as predicted in 
[28]. The fhuB gene should contain a specific opera- 
tor sequence to accommodate he hypothesized func- 
tion of the TonB protein as its positive regulator. 
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Although 2 different classes of phenotype have 
been shownforfep (A t B) mutants [51], btu (B t A) 
mutants [71] and fee (A + B) mutants [72] and these 
classes have different cotransduction frequencies with 
neighbouring enetic markers, complementation a aly- 
sis has yielded only single classes with fep [73] and btu 
mutants [48]. While 2 fhu genes have been shown by 
merodiploid analysis, only negative complementation 
results have been obtained with fep and btu mutants. 
3.2.77re tonBgeneproduct involved inpost-transcrip- 
tional modification (l(b)) 
In view of the contradictions to (l(a)) presented 
by the putative single cistron, a function of TonB pro- 
tein in post-translational modification of transport 
proteins can be envisaged. Thus in fep, btu and per- 
haps fee systems, the TonB function would involve 
modification of the receptor protein so that it 
remained functional within the cytoplasmic mem- 
brane as the permease. This could occur by a specific 
cleavage of the receptor protein during its extrusion 
through the membrane. A mutant defective in the 
activity of a TonBdependent permease would also 
have a corresponding defunct receptor activity; how- 
ever, the reverse would not necessarily occur. Thus 
mutants that were fepB could also be fepA with 
respect o ferric enterochelin transport. But strains 
which were fepA may have a functional FepB per- 
mease, since the defective part of the FepA may be 
cleaved off by the tonB gene product. A similar argu- 
ment could apply to the btu system. In this case no 
genetic omplementation f fepA and fepB would be 
anticipated. 
In the fhu A/B system TonB function would 
involve the post-translational modification of the 
jhuB gene product. Proteases, like the recA gene prod- 
uct, specifically cleave certain proteins like the h 
immunity repressor [75,76]. The observation that the 
TonB protein was associated with the cytoplasmic 
membrane [33] would fit with its proposed function 
in the post-translational modification of transport 
proteins as they pass through the membrane. 
3.3. Permeases of TonB-dependent systems are jknc- 
tionally unstable (2) 
Two sources of information support his proposi- 
tion: 
(i) When a tonB (Am) mutation was introduced into 
a supDts background and incubated at non-per- 
missive temperature, the uptake of vitamin Brz 
and the sensitivity to colicin D (both TonB-depen- 
dent) decreased at a rate far greater than the sen- 
sitivity to phage BF23 which is dependent on the 
vitamin Br2 receptor but is TonBindependent 
[42]. This was interpreted as meaning that the 
TonB function is relatively unstable. Following 
this hypothesis, the TonB protein would not be 
synthesized at the non-permissive t mperature 
and the permease function would decline rapidly 
due to the lack of positive regulation of the per- 
mease gene and the proposed inherent instability 
of the permease protein. 
(ii) Vesicles which accumulate f rric enterochelin are 
extremely difficult to prepare (unpublished) 
although good proline transport is possible. Lim- 
ited uptake of ferrichrome into vesicles has been 
reported [77] although accumulation rates were 
very low. If the permeases are unstable continu- 
ous protein synthesis would be required to main- 
tain the functional stability of the transport sys- 
tems [44]. Some membrane-bound proteins are 
unstable [78]. 
3.4. l%e action of group B colicins requires functional 
cytoplasmic membrane proteins, some or all of 
which, may be TonBdependent permeases (3) 
Many fepB and fhuB strains are tolerant o col- 
icin B [Sl] and colicin M [SO], respectively. Colicin 
M-tolerant strains were selected on the basis of their 
albomycin resistance, mapped in the dapD region [9] 
and were unable to accumulate f rrichrome after the 
outer membrane had been made permeable by prior 
pronase treatment [50]. The frequency of colicin- 
tolerant fepB strains or fhuB strains is low. 
3.5. The irreversible binding of phage T1 and Gru, 
requires a cytoplasmic membrane protein which 
may be the tonB gene product or some protein 
produced as a result of the proposed positive 
regulator activity of the TonB protein (4) 
The N protein, which is a positive regulator protein 
for some genes of X phage, increases the interaction 
between h and the membranes of the host cell [81]. 
Whether this is a result of insertion of the N protein 
into the membrane or indirectly by the insertion of 
another protein, itself regulated by the N protein, is 
unclear. The TonB protein is present in the cytoplas- 
mic membrane fraction after sarkosyl treatment [33]. 
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4. Conclusion 
This hypothesis accommodates the observation that 
a large number of tonB strains, many of which are 
deletions, are isolated from strains resistant to albo- 
mycin and unable to utilise ferrichrome as an iron 
source. It explains why the uptake of ferric entero- 
chelin, ferrichrome, ferric citrate and vitamin Brz is 
not observed in to& strains, without invoking an 
energy coupling argument. The energy-dependent 
phase of transport is absent in tonB strains, due to 
the low expression of cytoplasmic permeases, rather 
than the coincident ability to couple energy from the 
membrane potential. 
Low levels of FepB permease can be produced in a 
tonB strain, allowing limited accumulation (‘leak’) 
and growth to occur in the presence of ferric entero- 
chelin. The data in [3] were explained by the ferric 
enterochelin/enterochelin ratio being rate limiting for 
growth when low levels of FepB permease were bio- 
synthesized in a tonB strain. 
The instability of TonB-dependent permeases had 
been attributed to the TonB function [42,44], on the 
finding that vitamin Bra uptake decreases ata greater 
rate than the sensitivity to phage BF23 after the tonB 
gene had been made non-functional. Since the TonB 
protein would be involved in the expression of the 
relevant permeases, in this case the vitamin Brz per- 
mease , and since this permease isrelatively unstable, 
the hypothesis accommodates the finding. The require- 
ment of continuous protein synthesis for vitamin Brz 
uptake is also explained by the instability of the 
TonB-dependent permeases. This instability may be 
an adaptation in E. coli to protect itself against antag- 
onists like group B colicins and certain phage, after 
the supply of iron for cell growth has been satisfied. 
That ferrichrome and ferric enterochelin can 
induce resistance to group B colicins, and that this 
resistance occurs by specific inhibition at the level of 
the receptor and by the availability of iron [ 181, can 
be explained by the inactivation (or repression of the 
tonB gene) of the function of TonB protein and the 
consequent lack of expression of cytoplasmic mem- 
brane proteins necessary for group B colicin action. 
That both ferrichrome and dihydroxybenzoate, the 
precursor of ferric enterochelin, decrease the uptake 
of vitamin Br2 [43], is similarly explained: iron in 
sufficient quantities decreases the expression of the 
permease for vitamin Br2 transport, via a decrease in 
the activity of the TonB protein. 
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This hypothesis postulates that facilitated iffusion 
takes place at the outer membrane whereas active 
accumulation isrestricted to processes across and sur- 
rounding the cytoplasmic membrane. The cytoplas- 
mic membrane isunique for its coupling of energy 
production from respiration and ATP hydrolysis to 
energy utilization (transport and oxidative phospho- 
rylation) in a chemiosmotic manner. As this hypothe- 
sis assumes accepted theories of regulation and post- 
transcriptional modification it should be readily cor- 
roborated. 
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